iRhythm Stock Gains Following Favorable Zio Monitor Study Data

iRhythm Technologies (IRTC) recently announced initial research findings on the post-market, real-world performance of the Zio monitor, IRTC's next-generation Zio long-term continuous monitoring (LTCM) patch ECG device. The findings are presented at the Heart Rhythm Society's HRX 2024 meeting. The impact of design enhancements on device performance, with even better wear time and analyzable time with the new device, was observed in the findings. Taken together, these advancements are likely to contribute to ...